logo

For the Inventor, By the Inventor

Toronto, Canada

Wendy Alison Naimark

This inventor holds 8 USPTO granted patents and 13 published patent applications. Top assignees: Ripple Therapeutics Corporation, Interface Biologics, Inc.. Active years: 2020-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wendy Alison Naimark. Retrieved from https://idiyas.com/inventor/wendy-alison-naimark

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 100.0

Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 16(Granted Patents)


Location History:

  • Toronto, CA (2020 - 2022)
  • Tornto, CA (2023)

Company Filing History:

goldMedal7 out of 9 
 
Ripple Therapeutics Corporation
 patents
silverMedal1 out of 21 
 
Interface Biologics, Inc.
 patents

Years Active: 2020-2025

Loading Chart...
8 patents (USPTO):Explore Patents
1. 12509469 - Compositions and methods for the treatment of pain and dependence disorders (2025-12-30),
2. 11612567 - Ocular inserts comprising a covalently linked steroid dimer (2023-03-28),
3. 11318232 - Compositions and methods for delivering drugs to a vessel wall (2022-05-03),
4. 11279729 - Heterodimer compositions and methods for the treatment of ocular disorders (2022-03-22),
5. 10959954 - Dexamethasone prodrug compositions and uses thereof (2021-03-30),
6. 10945958 - Dexamethasone prodrug compositions and uses thereof (2021-03-16),
7. 10632075 - Glass formulations and uses thereof (2020-04-28),
8. 10588862 - Dexamethasone prodrug compositions and uses thereof (2020-03-17),

Title: Wendy Alison Naimark: Innovator in Ocular Therapeutics

Introduction

Wendy Alison Naimark is a prominent inventor based in Toronto, Canada. She has made significant contributions to the field of ocular therapeutics, holding a total of seven patents. Her innovative work focuses on developing advanced drug delivery systems that enhance therapeutic efficacy.

Latest Patents

Among her latest patents is the invention titled "Ocular inserts comprising a covalently linked steroid dimer." This patent relates to compounds and compositions designed for the sustained release of ocular therapeutics. Another notable patent is "Compositions and methods for delivering drugs to a vessel wall," which pertains to balloon coatings used in drug-eluting balloons for targeted drug delivery to vessel walls.

Career Highlights

Wendy has worked with several companies throughout her career, including Ripple Therapeutics Corporation and Interface Biologics, Inc. Her expertise in the field has allowed her to develop innovative solutions that address critical medical needs.

Collaborations

Wendy has collaborated with notable professionals in her field, including Ian Charles Parrag and Matthew Alexander John Statham. These partnerships have contributed to her success and the advancement of her inventions.

Conclusion

Wendy Alison Naimark is a trailblazer in ocular therapeutics, with a strong portfolio of patents that reflect her innovative spirit and dedication to improving healthcare. Her work continues to influence the development of effective drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…